Literature DB >> 8125393

Enteral nutrition as primary therapy in Crohn's disease.

F Fernández-Bañares1, E Cabré, F González-Huix, M A Gassull.   

Abstract

The developments in enteral feeding for Crohn's disease in the past decade are critically reviewed. The advent of amino acid based chemically defined elemental diets signalled the end of 'total bowel rest' in the management of these patients. Subsequently, controlled clinical trials showed that elemental diets were as effective as corticosteroids in inducing clinical remission in patients with acute exacerbations of Crohn's disease. The later use of peptide based elemental diets, in Crohn's disease produced somewhat conflicting results. The initial uncontrolled studies suggest that polymeric whole protein diets might also be effective in the management of acute exacerbations of the disease, casting in turn doubts concerning the role of dietary antigens in the pathogenesis of Crohn's disease. Results of controlled studies comparing the use of elemental and polymeric diets as primary therapy in Crohn's disease have, however, also produced conflicting results. The results of one recent controlled trial in which the use of polymeric diet was compared with that of corticosteroids does, however, suggest that these diets may have a primary therapeutic effect in Crohn's disease. An analysis of the composition of some of the enteral diets used in different trials suggest that the effectiveness of enteral diets in treating active Crohn's disease might relate more to their fat than nitrogen composition. A hypothesis is proposed that the effectiveness of enteral nutrition in the primary therapy of acute exacerbations of Crohn's disease occurs because the successful diets used contain insufficient precursors for arachidonate derived eicosanoid synthesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8125393      PMCID: PMC1378149          DOI: 10.1136/gut.35.1_suppl.s55

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  34 in total

1.  Has total bowel rest a beneficial effect in the treatment of Crohn's disease?

Authors:  H Lochs; S Meryn; L Marosi; P Ferenci; H Hörtnagl
Journal:  Clin Nutr       Date:  1983-04       Impact factor: 7.324

2.  Enteral nutrition in inflammatory bowel disease.

Authors:  M A Gassull; A Abad; E Cabré; F González-Huix; J J Giné; C Dolz
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

3.  Ten years experience with intravenous hyperalimentation and inflammatory bowel disease.

Authors:  J L Mullen; W C Hargrove; S J Dudrick; W T Fitts; E F Rosato
Journal:  Ann Surg       Date:  1978-05       Impact factor: 12.969

4.  Hyperalimentation as primary therapy for inflammatory bowel disease.

Authors:  J E Fischer; G S Foster; R M Abel; W M Abbott; J A Ryan
Journal:  Am J Surg       Date:  1973-02       Impact factor: 2.565

5.  A working hypothesis for the etiology and pathogenesis of nonspecific inflammatory bowel disease.

Authors:  R G Shorter; K A Huizenga; R J Spencer
Journal:  Am J Dig Dis       Date:  1972-11

6.  Essential fatty acid depletion of renal allografts and prevention of rejection.

Authors:  G F Schreiner; W Flye; E Brunt; K Korber; J B Lefkowith
Journal:  Science       Date:  1988-05-20       Impact factor: 47.728

7.  Diet in the management of Crohn's disease.

Authors:  A J Levi
Journal:  Gut       Date:  1985-10       Impact factor: 23.059

8.  The pathogenesis of Crohn's disease.

Authors:  M Ward
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

9.  Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial.

Authors:  F González-Huix; R de León; F Fernández-Bañares; M Esteve; E Cabré; D Acero; A Abad-Lacruz; M Figa; M Guilera; R Planas
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

10.  Total parenteral nutrition and complete bowel rest in the management of Crohn's disease.

Authors:  M J Ostro; G R Greenberg; K N Jeejeebhoy
Journal:  JPEN J Parenter Enteral Nutr       Date:  1985 May-Jun       Impact factor: 4.016

View more
  13 in total

Review 1.  Therapy of Crohn's disease in childhood.

Authors:  R M Beattie
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

Review 2.  Diagnosis of gastroenterological diseases by metabolome analysis using gas chromatography-mass spectrometry.

Authors:  Masaru Yoshida; Naoya Hatano; Shin Nishiumi; Yasuhiro Irino; Yoshihiro Izumi; Tadaomi Takenawa; Takeshi Azuma
Journal:  J Gastroenterol       Date:  2011-11-02       Impact factor: 7.527

Review 3.  Impact of environmental and dietary factors on the course of inflammatory bowel disease.

Authors:  Eduard Cabré; Eugeni Domènech
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

4.  Dietary fat intake and inflammatory bowel disease.

Authors:  M A Gassull
Journal:  Curr Gastroenterol Rep       Date:  2001-08

5.  Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial.

Authors:  T Johnson; S Macdonald; S M Hill; A Thomas; M S Murphy
Journal:  Gut       Date:  2005-09-14       Impact factor: 23.059

6.  Supplementary enteral nutrition maintains remission in paediatric Crohn's disease.

Authors:  M Wilschanski; P Sherman; P Pencharz; L Davis; M Corey; A Griffiths
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

7.  The effects of an oral supplement enriched with fish oil, prebiotics, and antioxidants on nutrition status in Crohn's disease patients.

Authors:  Dawn M Wiese; Bret A Lashner; Edith Lerner; Stephen J DeMichele; Douglas L Seidner
Journal:  Nutr Clin Pract       Date:  2011-08       Impact factor: 3.080

8.  A randomised controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn's disease.

Authors:  K Leiper; J Woolner; M M Mullan; T Parker; M van der Vliet; S Fear; J M Rhodes; J O Hunter
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

9.  GC/MS-based profiling of amino acids and TCA cycle-related molecules in ulcerative colitis.

Authors:  Makoto Ooi; Shin Nishiumi; Tomoo Yoshie; Yuuki Shiomi; Michitaka Kohashi; Ken Fukunaga; Shiro Nakamura; Takayuki Matsumoto; Naoya Hatano; Masakazu Shinohara; Yasuhiro Irino; Tadaomi Takenawa; Takeshi Azuma; Masaru Yoshida
Journal:  Inflamm Res       Date:  2011-04-27       Impact factor: 4.575

10.  Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial.

Authors:  M A Gassull; F Fernández-Bañares; E Cabré; M Papo; M H Giaffer; J L Sánchez-Lombraña; C Richart; H Malchow; F González-Huix; M Esteve
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.